BRÈVE

sur Menarini Industrie Farmaceutiche Riunite

Thomas Cueni Joins Menarini Group's Board

The Menarini Group, based in Florence, has appointed Thomas Cueni as a new member of its Board of Directors. Cueni's extensive experience in the pharmaceutical sector includes significant roles such as Director General of the International Federation of Pharmaceutical Manufacturers & Associations and board member of the European Federation of Pharmaceutical Industries and Associations.

Cueni's appointment is expected to boost Menarini's governance. His expertise in addressing global health challenges, notably through initiatives like the AMR Action Fund, aligns well with Menarini's mission of combining innovation and responsibility in patient care.

The company, operating in 140 countries, reported a consolidated turnover of €4.88 billion and employs over 17,000 people. Recognized for its commitment to R&D, Menarini plays a significant role in fields including cardiometabolic and oncology.

R. E.

Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de Menarini Industrie Farmaceutiche Riunite